Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

Clinical trial NCT02820844 · COMPLETED

Trial details

NCT number: NCT02820844
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2016-08-10
Primary completion: 2018-03-06
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.